LipiDiDiet: multinutrient drink shows positive impact against prodromal Alzheimer’s disease

Written by Alice Bough (Future Science Group)

The LipiDiDiet clinical study group, including individuals from the University of Eastern Finland (Kuopio, Finland) and Saarland University (Homburg, Germany), have determined that long-term use of a multinutrient drink can slow progression of symptoms associated with prodromal Alzheimer’s disease. The authors of the paper, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, propose that the drink could be used as an intervention treatment for individuals showing early signs of cognitive decline. The LipiDiDiet treatment consists of the commercially available medical food ‘Fortasyn Connect’, which contains a combination of essential fatty acids, vitamins and other nutrients. Previous studies...

To view this content, please register now for access

It's completely free